AIMC Journal:
npj drug discovery

Artificial intelligence (AI) has transformed molecular prediction and design, yet these advances remain only partially integrated with experimental discovery. We define TechBio 3.0 as an emerging paradigm for closed-loop drug discovery that connects ...

Snake venoms are a rich source of bioactive molecules with considerable potential for drug discovery. Cardiotoxins (CTXs) from cobras (Naja spp.) are membrane-active venom proteins and promising templates for antimicrobial peptide development. Here, ...